Acute bronchitis: diagnosis and treatment


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article presents an overview of modern methods of diagnosis, treatment and prevention of acute bronchitis (AB). The prevalence of viral AB is emphasized; it raises questions about advisability of appointing antibacterial agents. The use of antibiotics for viral AB to prevent bacterial complications is also doubtful because effectiveness of this approach has no serious evidence. Influenzal bronchitis requires antiviral therapy using neuraminidase inhibitors. The choice of antitussives based on their mechanism of action and antitussive activity is discussed.

全文:

受限制的访问

作者简介

Andrey Zaitsev

N.N. Burdenko Main Military Clinical Hospital

Email: a-zaicev@yandex.ru
MD, Ohief pulmonologist

参考

  1. Bartlett J., Dowell S., Mandell, L., File Jr T.M., Musher D.M., Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis. 2000;31:347-82.
  2. Wenzel R., Fowler A. Acute втоп^і^. Clinical practice. N. Engl. J. Med. 2006;355:2125-30.
  3. Albert R. Diagnosis and treatment of acute bronchitis. Am. Fam. Physician. 2010;82(11):1345-50.
  4. Зайцев А.А. Острый бронхит. Фарматека. 2015;14:92-7. [Zaitsev A.A. Acute bronchitis. Pharmateca. 2015;14:92-7 (in Russ.)]
  5. Worrall G. Acute bronchitis. Can. Fam. Physician. 2008;54(2):238-9.
  6. Knutson D., Braun C. Diagnosis and management of acute bronchitis. Am. Fam. Physician. 2002;65(10):2039-44.
  7. Wark P. Bronchitis (acute). Clin. Evid. 2011:1508.
  8. Meza R.A. The management of acute bronchitis in general practice results from the Australian morbidity and treatment survey. Aust. Fam. Physician. 1994;23:1550-3.
  9. Ott S., Rohde G., Lepper P., Hauptmeier B., Bals R., Pletz M.W., Schumann C., Steininger C., Kleines M., Geerdes-Fenge H. The impact of viruses in lower respiratory tract infections of the adult. Part II: acute bronchitis, acute exacerbated COPD, pneumonia, and influenza. Pneumologie. 2010;64(1):18-27.
  10. Зайцев А.А., Овчинников Ю.В., Кондратьева Т.В. Биологические маркеры воспаления при внебольничной пневмонии. Consilium medicum. 2014;11:36-41. [Zaitsev A.A., Ovchinnikov Yu.V., Kondrat'eva T.V. Biological markers of inflammation in community-acquired pneumonia. Consilium medicum. 2014;11:36-41 (in Russ.)]
  11. Woodhead M., Blasi F., Ewig S., Garau J., Huchon G., Ieven M., Ortqvist A., Schaberg T., Torres A., van der Heijden G., Read R., Verheij T.J. Guidelines for the management of adult lower respiratory tract infections - full version. Clin. Microbiol. Infect. 2011; Suppl. 6:E1-59.
  12. Bent S., Saint S., Vittinghoff E., Grady D. Antibiotics in acute bronchitis: a meta-analysis. Am. J. Med. 1999;107:62-7.
  13. Huang N., Morlock L., Lee C.-H., Chen L.-S., Chou Y.-J. Antibiotic prescribing for children with nasopharyngitis (Common Colds), upper respiratory infections, and bronchitis. Who have health-professional parents. Pediatrics. 2005;116(4):826-32.
  14. Llor C., Moragas A., Bayona C., Morros R., Pera H., Cots J.M., Fernandez Y., Miravitlles M., Boada A. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm. Med. 2011;11:38.
  15. Smucny J., Fahey T., Becker L., Glazier R., McIsaac W. Antibiotics for acute bronchitis. Cochrane Database Syst. Rev. 2000;4:245.
  16. Зайцев А.А., Оковитый С.В. Кашель: дифференциальная диагностика и фармакотерапия. Терапевтический архив. 2014;12:85-91. [Zaitsev A.A., Okovity S.V. Cough: differential diagnosis and pharmacotherapy. Therapeutic archive. 2014;12:85-91 (in Russ.)]
  17. Smucny J., Flynn C., Becker L., Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst. Rev. 2004;1:1726.
  18. Evrard Y., Kato G., Bodinier M. C., Chapelean B. Fenspiride and inflammation in experimental pharmacology. Eur. Resp. rev., 1991;1(rev. 2):93-100.
  19. Lima M. C. R., Hatmi M., Martins M. A., Silva P.M., Malanchère E., Cordeiro R.N., Vargaftig B.B. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride. Rhinology. 1988;4:85-92.
  20. Olivieri D., Del Donno M. Efficacy of fenspiride on mucociliary transport. Double-blind with placebo trial. Bull. Eur. Physiopathol. Respir. 1987;23 (Suppl. 12).
  21. Pinelli E., Cambon C., Crambes O., Pipy B. Inhibition of LPS-induced TNF-alfa production in mouse inflammatory macrophages by fenspiride. Eur. Resp. J. 1993;6 (Suppl. 17):3055-P0776.
  22. Плуса Т., Новацка Д. Эффективность и переносимость фенсперида у взрослых больных с острыми респираторными заболеваниями. Лечащий врач. 2000;1:51-3. [Plusa T., Novatska D. Efficacy and tolerability of fenspiride in adult 35 patients with acute respiratory diseases. Lechashchiy vrach. 2000;1:51-3 (in Russ.)]
  23. Белевский А.С. Возможности оптимизации терапии острых бронхитов на фоне ОРВИ. Лечащий врач. 2001;8:58-61. [Belevsky A.S. Possibility of optimizing the treatment of acute bronchitis on the background of acute respiratory viral infections. Lechashchiy vrach. 2001;8:58-61 (in Russ.)]
  24. Романова Т.А., Сысоева Н.Я., Руднева Е.И., Рубцова Л.В., Восковская Л.Н. Клиническая эффективность препарата Эреспал в комплексном лечении острого обструктивного бронхита у детей. Педиатрия. 2013;92(5):98-102. [Romanova T.A., Sysoeva N.Ya., Rudneva Ye.I., Rubtsova L.V, Voskovskaya L.N. Clinical efficacy of Eurespal in complex treatment of acute obstructive bronchitis in children. Pediatrics. 2013;92(5):98-102 (in Russ.)]

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2017
##common.cookie##